Potential Role of Garcinol as an Anticancer Agent

Table 1

List of studies investigating the role of Garcinol in different cancer types.

Type of cancer	Study type	Experimental details	Reference
Breast cancer	In vitro	MDA, MB231, MCF-7	[16]
	In vitro	MCF-7, MDA-MB231	[17]
	In vitro	Primary culture, MCF-7 MDA-MB231, AU 565 BT-483	[18]
Burkitt lymphoma	In vitro	TPA induced Ebvirus-EA activated raji cells	[19]
Colon cancer	In vitro	HT-29, HCT-116	[16]
	In vitro	HT-29, HCT-116, ICE-6	[20]
	In vitro	HT-29	[21]
	In vivo	Azoxymethane induced colonic aberrant crypt foci F344 rats	[15]
Esophageal cancer	In vitro	SEG-1	[16]
Hepatocellular carcinoma	In vitro	MH1C1-HEP G2	[22]
	In vivo	Hep3B	[23]
	In vitro	Carcinogen induced liver cancer F344 rats	[24]
HeLa cells	In vitro	HeLa core Histones-P300 HAT inhibition	[25]
	In vitro	HeLa Histones	[26]
Kidney cancer	In vitro	A293 (Human embryonic kinder carcinoma)	[16]
Leukemia	In vitro	KBM-5 (chronic Leukemia)	[16]
	In vitro	U937, K562, NB4, HL60	[27]
	In vitro	HL-60	[28]
	In vitro	HL-60	[15]
Lung cancer	In vitro	A-549	[29]
Medulloblastoma	In vitro	Daoy, growth factor,	[24]
Multiple myeloma	In vitro	U-266	[16]
Pancreatic cancer	In vitro	BxPC3	[30]
	In vitro	Panc-1, BxPC-3	[31]
Prostate cancer	In vitro	LNCaP, C4-2B, PC-3	[30]
	In vitro	PC-3	[16]
Tongue cancer	In vivo	4-nitroquinoline 1-oxide induced oral carcinogenesis in F344 rats	[32]